Clinical Outcomes of Minimally Invasive Surfactant Therapy via Tracheal Catheterization in Neonates with a Gestational Age of 30 Weeks or More Diagnosed with Respiratory Distress Syndrome

Purpose Minimally invasive surfactant therapy (MIST) is currently used as a method of surfactant replacement therapy (SRT) for the treatment of respiratory distress syndrome (RDS) in preterm infants with a gestational age of less than 30 weeks. However, few studies have been conducted on MIST in neo...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Moon Young Seo, Gyu Hong Shim, Myoung Jae Chey
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Korean Society of Neonatology 2018-08-01
Rangatū:	Neonatal Medicine
Ngā marau:	noninvasive ventilation minimally invasive surfactant therapy respiratory distress syndrome mechanical ventilation bradycardia
Urunga tuihono:	http://www.neo-med.org/upload/pdf/nm-2018-25-3-109.pdf
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!